Literature DB >> 6312557

High dose intravenous IgG reduces platelet associated immunoglobulins and complement in idiopathic thrombocytopenic purpura.

J Winiarski, A Kreuger, J Ejderhamn, G Holm.   

Abstract

4 children with idiopathic thrombocytopenic purpura were treated with high dose i.v. IgG. Platelet associated immunoproteins were determined with an Elisa technique. Platelet counts increased in all patients, while simultaneously platelet associated IgG, IgA, IgM, C3 and C4 decreased. Serum antiplatelet antibody increased during treatment suggesting that administration of high doses of IgG interferes with the binding of antiplatelet antibody.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6312557     DOI: 10.1111/j.1600-0609.1983.tb00662.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  3 in total

Review 1.  Mechanism of action of intravenous immunoglobulin in immune-mediated cytopenias.

Authors:  H I Atrah; R J Davidson
Journal:  J Clin Pathol       Date:  1988-12       Impact factor: 3.411

2.  The clinical use of intravenous immunoglobulin in pediatrics.

Authors:  V Wahn
Journal:  Indian J Pediatr       Date:  1987 Sep-Oct       Impact factor: 1.967

3.  Treatment of severe thrombocytopenia in systemic lupus erythematosus with intravenous gammaglobulin.

Authors:  E J ter Borg; C G Kallenberg
Journal:  Ann Rheum Dis       Date:  1992-10       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.